Asensus Surgical, Inc.

ASXC · AMEX
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$25,749-$22,497-$17,235-$18,318
Dep. & Amort.$951$955$984$867
Deferred Tax$0$0-$4$57
Stock-Based Comp.$0$1,745$2,005$2,019
Change in WC$472$483-$833$2,556
Other Non-Cash$13,829$6,818$1,709-$2,230
Operating Cash Flow-$14,220-$14,008-$13,374-$15,049
Investing Activities
PP&E Inv.-$111$0-$73-$322
Net Acquisitions$0$0$36,467$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$3,000$7,500$21,100
Other Inv. Act.$0$3,000-$36,467$21,100
Investing Cash Flow-$111$3,000$7,427$20,778
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$982$172$9,750
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$14,995-$171$0-$7
Financing Cash Flow$15,080$811$172$9,743
Forex Effect$0-$63$1,229-$1,217
Net Chg. in Cash$787-$10,101-$4,573$14,255
Supplemental Information
Beg. Cash$6,995$17,096$21,669$9,029
End Cash$7,782$6,995$17,096$23,284
Free Cash Flow-$14,331-$14,008-$13,447-$15,371